As the recipient of the Thomsen Family Breast Cancer Research Fellowship, I was invited to speak about my work on chemotherapy resistance in breast cancer at a gathering of the Breast Cancer Research Institute. In the audience were breast cancer clinicians (surgeons, oncologists, radiologists) and research scientists (basic scientists, translational biologists, epidemiologists) from the Fred Hutch/Seattle Cancer Care Alliance and the University of Washington.
This was a rare opportunity for both clinicians and basic science researchers to share data and have the opportunity to collectively help move the field forward. Following my presentation and presentations by other award recipients, there was a round-table discussion to do exactly that. We were provided with a list of directives to guide how breast cancer research should be funded at the local level and, as a table, asked to provide feedback on those directives.
My table consisted of one other basic scientist and three radiologists who develop and modify MRI techniques for early and better detection of breast tumors. As we discussed the merits of the listed directives, one of the radiologists shared that he thought large data-gathering consortia (which collect many different kinds of data from a large number of patients) may be a waste of resources as those efforts are not driven by a specific hypothesis (or idea) to be tested. The basic scientist and I responded that for us those large data-sets are invaluable! We can test hypotheses that we develop on non-clinical, lab-based experiments on patient data available in those data sets. A great discussion followed.
This anecdote demonstrates the importance of having such round-table discussions among researchers and clinicians. We can best evaluate effective strategies and the most appropriate use of resources working together. It was a rare opportunity to brainstorm with experts from different fields. All of our approaches and contributions may be different but we all share the same goal–improve survival from breast cancer by developing strategies to better prevent, detect, and treat this terrible disease.